Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Nan Fan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Chemical Communications (Cambridge, England)|July 9, 2015
Direct white-light and a dual-channel barcode module from Pr(III)-MOF crystalsBin-Bin Du, Yi-Xuan Zhu, Mei Pan, et al.
Nature Communications|July 23, 2024
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunityQian-Ni Ye, Long Zhu, Jie Liang, et al.
ACS Applied Materials & Interfaces|September 30, 2022
MIL-101-Cr/Fe/Fe-NH<sub>2</sub> for Efficient Separation of CH<sub>4</sub> and C<sub>3</sub>H<sub>8</sub> from Simulated Natural GasLu-Zhu Qin, Xiao-Hong Xiong, Shi-Han Wang, et al.
ACS Applied Materials & Interfaces|October 19, 2020
An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune ToleranceYing-Li Luo, Li-Fang Liang, Yun-Jiu Gan, et al.
Nature Biomedical Engineering|June 26, 2025
Engineering multi-specific nano-antibodies for cancer immunotherapyYa-Nan Fan, Long Zhu, Yu-Xin Qing, et al.
Nature Communications|March 2, 2021
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapyCheng-Tao Jiang, Kai-Ge Chen, An Liu, et al.
Journal of Viral Hepatitis|June 23, 2022
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or CJing-Hang Xu, Ya-Nan Fan, Yan-Yan Yu, et al.
World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Chemical Communications (Cambridge, England)|July 9, 2015
Direct white-light and a dual-channel barcode module from Pr(III)-MOF crystalsBin-Bin Du, Yi-Xuan Zhu, Mei Pan, et al.
Nature Communications|July 23, 2024
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunityQian-Ni Ye, Long Zhu, Jie Liang, et al.
ACS Applied Materials & Interfaces|September 30, 2022
MIL-101-Cr/Fe/Fe-NH<sub>2</sub> for Efficient Separation of CH<sub>4</sub> and C<sub>3</sub>H<sub>8</sub> from Simulated Natural GasLu-Zhu Qin, Xiao-Hong Xiong, Shi-Han Wang, et al.
ACS Applied Materials & Interfaces|October 19, 2020
An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune ToleranceYing-Li Luo, Li-Fang Liang, Yun-Jiu Gan, et al.
Nature Biomedical Engineering|June 26, 2025
Engineering multi-specific nano-antibodies for cancer immunotherapyYa-Nan Fan, Long Zhu, Yu-Xin Qing, et al.
Nature Communications|March 2, 2021
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapyCheng-Tao Jiang, Kai-Ge Chen, An Liu, et al.
Journal of Viral Hepatitis|June 23, 2022
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or CJing-Hang Xu, Ya-Nan Fan, Yan-Yan Yu, et al.
World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.
Pageof 4